343 related articles for article (PubMed ID: 7857696)
1. Evaluation of the genetic toxicity of the peroxisome proliferator and carcinogen methyl clofenapate, including assays using Muta Mouse and Big Blue transgenic mice.
Lefevre PA; Tinwell H; Galloway SM; Hill R; Mackay JM; Elcombe CR; Foster J; Randall V; Callander RD; Ashby J
Hum Exp Toxicol; 1994 Nov; 13(11):764-75. PubMed ID: 7857696
[TBL] [Abstract][Full Text] [Related]
2. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the potential carcinogenicity and genetic toxicity to humans of the herbicide acetochlor.
Ashby J; Kier L; Wilson AG; Green T; Lefevre PA; Tinwell H; Willis GA; Heydens WF; Clapp MJ
Hum Exp Toxicol; 1996 Sep; 15(9):702-35. PubMed ID: 8880207
[TBL] [Abstract][Full Text] [Related]
4. The peroxisome proliferations WY-14,643 and methylclofenapate induce hepatocyte ploidy alterations and ploidy-specific DNA synthesis in F344 rats.
Miller RT; Shah RS; Cattley RC; Popp JA
Toxicol Appl Pharmacol; 1996 Jun; 138(2):317-23. PubMed ID: 8658533
[TBL] [Abstract][Full Text] [Related]
5. The genetic toxicity of the peroxisome proliferator class of rodent hepatocarcinogen.
Galloway SM; Johnson TE; Armstrong MJ; Ashby J
Mutat Res; 2000 Mar; 448(2):153-8. PubMed ID: 10725469
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue transgenic mouse mutation assay.
Suter W; Ahiabor R; Blanco B; Locher F; Mantovani F; Robinson M; Sreenan G; Staedtler F; Swingler T; Vignutelli A; Perentes E
Environ Mol Mutagen; 1996; 28(4):354-62. PubMed ID: 8991064
[TBL] [Abstract][Full Text] [Related]
7. Relative activities of methyl methanesulphonate (MMS) as a genotoxin, clastogen and gene mutagen to the liver and bone marrow of MutaMouse mice.
Tinwell H; Lefevre PA; Ashby J
Environ Mol Mutagen; 1998; 32(2):163-72. PubMed ID: 9776179
[TBL] [Abstract][Full Text] [Related]
8. Thalidomide: lack of mutagenic activity across phyla and genetic endpoints.
Ashby J; Tinwell H; Callander RD; Kimber I; Clay P; Galloway SM; Hill RB; Greenwood SK; Gaulden ME; Ferguson MJ; Vogel E; Nivard M; Parry JM; Williamson J
Mutat Res; 1997 Dec; 396(1-2):45-64. PubMed ID: 9434859
[TBL] [Abstract][Full Text] [Related]
9. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
Irwin RD
Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
[TBL] [Abstract][Full Text] [Related]
10. Species differences in hepatic peroxisome proliferation, cell replication and transforming growth factor-beta1 gene expression in the rat, Syrian hamster and guinea pig.
Lake BG; Rumsby PC; Price RJ; Cunninghame ME
Mutat Res; 2000 Mar; 448(2):213-25. PubMed ID: 10725474
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
Kirkland D; Aardema M; Henderson L; Müller L
Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
[TBL] [Abstract][Full Text] [Related]
12. Collaborative study on fifteen compounds in the rat-liver Comet assay integrated into 2- and 4-week repeat-dose studies.
Rothfuss A; O'Donovan M; De Boeck M; Brault D; Czich A; Custer L; Hamada S; Plappert-Helbig U; Hayashi M; Howe J; Kraynak AR; van der Leede BJ; Nakajima M; Priestley C; Thybaud V; Saigo K; Sawant S; Shi J; Storer R; Struwe M; Vock E; Galloway S
Mutat Res; 2010 Sep; 702(1):40-69. PubMed ID: 20656055
[TBL] [Abstract][Full Text] [Related]
13. Toxicology and carcinogenesis studies of methylene blue trihydrate (Cas No. 7220-79-3) in F344/N rats and B6C3F1 mice (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2008 May; (540):1-224. PubMed ID: 18685714
[TBL] [Abstract][Full Text] [Related]
14. Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene.
Hayward JJ; Shane BS; Tindall KR; Cunningham ML
Carcinogenesis; 1995 Oct; 16(10):2429-33. PubMed ID: 7586147
[TBL] [Abstract][Full Text] [Related]
15. A species comparison of acute hyperplasia induced by the peroxisome proliferator methylclofenapate: involvement of the binucleated hepatocyte.
Styles JA; Kelly M; Pritchard NR; Elcombe CR
Carcinogenesis; 1988 Sep; 9(9):1647-55. PubMed ID: 3409467
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo genotoxicity assessment of the dopamine receptor antagonist molindone hydrochloride.
Krishna G; Gopalakrishnan G; Goel S
Environ Mol Mutagen; 2016 May; 57(4):288-98. PubMed ID: 27040600
[TBL] [Abstract][Full Text] [Related]
17. In vivo micronucleus test in mice with 1-phenylethanol.
Engelhardt G
Arch Toxicol; 2006 Dec; 80(12):868-72. PubMed ID: 16944102
[TBL] [Abstract][Full Text] [Related]
18. Oxymetholone: I. Evaluation in a comprehensive battery of genetic toxicology and in vitro transformation assays.
Holden HE; Studwell D; Majeska JB
Toxicol Pathol; 1999; 27(5):501-6. PubMed ID: 10528628
[TBL] [Abstract][Full Text] [Related]
19. Micronucleus induction in rat liver and bone marrow by acute vs. repeat doses of the genotoxic hepatocarcinogen monocrotaline.
Takashima R; Takasawa H; Wako Y; Yasunaga K; Hattori A; Kawabata M; Nakadate K; Nakagawa M; Hamada S
Mutat Res Genet Toxicol Environ Mutagen; 2015 Mar; 780-781():64-70. PubMed ID: 25892625
[TBL] [Abstract][Full Text] [Related]
20. Promotional activities of the non-genotoxic carcinogen bemitradine (SC-33643).
Gad SC; Burton E; Chengelis CP; Levin S; Piper CE; Oshiro Y; Semler DE
J Appl Toxicol; 1992 Jun; 12(3):157-64. PubMed ID: 1629511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
